All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Migrants with HIV/AIDS account for 19.4% of 25,995 patients registered in Japan since 1985 \[[@pone.0205184.ref001]\]. Despite a marginal decrease in the number of newly reported cases in recent years, the number of new foreign cases remains stable, implying that the proportion of migrant patients is increasing \[[@pone.0205184.ref001]\]. Among newly reported migrant cases in 2016, 75% were non-AIDS HIV carriers \[[@pone.0205184.ref001]\], suggesting that early treatment and prevention of secondary infection are the focus of care at the hospital.

The initial impression of staff is a key determinant of retention in HIV care. Research shows that higher satisfaction with the initial visit correlates with better retention in care \[[@pone.0205184.ref002]\]. Furthermore, the initial communication at the hospital is considerably important among patients of foreign origin for successful establishment of HIV care. In this regard, the hospital is usually one of the most dominant sources of the necessary information. On the other hand, disappointment in service may force foreign patients to give up on treatment. Limited communication also makes the initial visit more difficult for patients of foreign origin.

The Japanese health policy guarantees provisions of essential medical care regardless of the patient's country of origin as long as the beneficiaries cover the cost \[[@pone.0205184.ref003]\]. Although most of the main antiretroviral (ARV) drugs are readily available in Japan, the average cost of antiretroviral therapy (ART) is usually not affordable. A standard ART can cost as much as JPY 7,000 (equivalent to USD 70.00) per day \[[@pone.0205184.ref004]\]. Therefore, most of the patients cannot afford lifelong ART without the support of the Government-sponsored public medicare and the public health care cost subsidy for individuals with disabilities. The public health insurance (either National Health Insurance or Social Health Insurance for Laborers) covers 70% of the standard medical cost, and the subsidy for persons with disabilities, namely, "Jiritsu-Shien-Kosei-Iryou　身体障害者自立支援更生医療" or "Judo-Shin-Shin Shogaisya-Iryou-Hi-Josei 重度心身障害者医療費助成," covers the rest. As long as the patient has legal status and a permanent visa in Japan, eligibility is defined solely by their physical status. If patients are eligible for the subsidy, they do not pay more than JPY 20,000 per month; the public support system pays the remainder \[[@pone.0205184.ref005]\].

A proportion of migrants is probably not aware of the above public aid systems because of the complexity of the application process at government offices, where the general staff does not speak foreign languages. Therefore, the hospital is usually the first gateway to accessing this information. Some non-Japanese patients may face particular difficulties, such as legal status or visa restrictions. Nevertheless, the top priority should be improving communication, because problems cannot be solved without an active communication gateway.

The AIDS Clinical Center (ACC), the National Center for Global Health and Medicine (NCGM), located in Tokyo, Japan, is one of the leading clinical research institutions of HIV/AIDS care and treatment. Since its establishment in 1997, over 4,014 patients with HIV/AIDS nationwide (15.4% of nationally registered cases) have visited the ACC to seek professional care and treatment. Migrant PLWHA formed approximately 10% of the patients in the past decade. The number of international visitors is expected to rise in line with global economic changes and the forthcoming Tokyo Olympic-Paralympic Games in 2020. Therefore, the ACC is preparing to improve their reception of foreign patients with HIV/AIDS. As part of these efforts, we use English or professional interpreters as alternative tools of communication. We proactively refer migrant patients to another facility when it is deemed appropriate, for example, for the availability of language service. We attempted to minimize the transfer time by arranging it as soon as we expected the completion of the initial phase assessment and treatment, expecting an early referral will reduce the risk of dropout.

The purpose of this study was to review the factors associated with retention of patients of foreign origin in HIV/AIDS care, and to evaluate the effectiveness of current approaches for migrant patients at our outpatient clinic (OPC).

Methods {#sec002}
=======

Among the patients who visited our OPC for clinical consultation between January 2011 and December 2014, we chose those who sought long-term HIV/AIDS care and had passed through the conventional initial visit process. We excluded those patients who did not require the routinely-applied clinical care during the initial visit, for instance, emergency care, direct admission, same day medical referral to another health facility, second opinion, medical care for people in detention (police cases), or temporary treatment for other specialties (e.g., obstetrics/gynecology) ([Fig 1](#pone.0205184.g001){ref-type="fig"}). The same inclusion criteria applied to both non-Japanese and Japanese patients.

![Flow diagram of patient selection.](pone.0205184.g001){#pone.0205184.g001}

We define non-Japanese by the nationality at birth principle, regardless of their country of origin. Migrants naturalized in Japan are grouped in original nationality by birth. In such a half-Japanese case whereby dual citizenship is given on account of being born in Japan, we grouped them with the nationality acquired at the age of adulthood \[[@pone.0205184.ref006]\]. No originally Japanese national who was born and brought up abroad participated in the study. The group of non-Japanese in this study is identical to migrants who intend to reside in Japan permanently, as the study's inclusion criteria outrightly excluded temporary visitors/travelers. We included migrants with expiring stay permits with a possibility of renewal or asylum seekers in the process of refugee status determination.

Based on the above criteria, we studied the records of 551 (78 migrant and 473 Japanese) patients. The records included both electronic versions and papers from the initial visit up to the end of 2015.

We defined retention as "the number of days from the initial date of visit to the last date of visit or December 31^st^, 2015 (the end of the study period) whichever came earlier". We considered "lost-to-follow-up (LTF)" as those who do not show up for an appointment without prior notice for more than one year. We treated the cases that terminated our follow-up within and before the end of 2015 as "censored". The reasons for censoring include transfer of care to another hospital or clinic, lost-to-follow-up, deaths and police custody.

The following data were collected from all participants: retention information (date of first visit, date of final visit, frequency of visits), data of patients' physical conditions on the first visit (CD4+ lymphocyte cell count, HIV-1 ribonucleic acid (RNA) load, HIV stage, period of time between initial visit and the date of diagnosis, history of antiretroviral therapy (ART).

For all non-Japanese cases, information on country of origin, Japanese language proficiency, an alternative method of communication (use of English, interpreter), and public health insurance eligibility was gathered. Additional information was collected from non-Japanese LTF cases to review the factors surrounding their HIV disclosure to someone else in order to understand their support network and ART availability in their country of origin.

We used Microsoft Excel and STATA 10 (College Station, TX) for statistical analysis. The collected data on retention were processed as person-time data for incident rate (IR) and incident rate ratio (IRR) analysis using a log-rank test or simple and multiple Poisson regression analyses. Variables in multivariable models were selected based on the result of univariable analysis. Cox proportional hazard model was used to evaluate the level of risk reduction. We partly applied a two-sample test for binomial proportions to compare the difference of baseline characteristics between Non-Japanese and Japanese. We adopted a significance level of *p* less than 0.05 for statistical tests throughout the study.

The institutional ethics review board of the National Center for Global Health and Medicine (NCGM) approved the study (No.1452, 2015). Informed consent of participants was waived by the board because of the non-invasive design of the study.

Results {#sec003}
=======

[Table 1](#pone.0205184.t001){ref-type="table"} shows the baseline characteristics of the study population with comparison between non-Japanese and Japanese patients. The number of new non-Japanese and Japanese patients by year remained constant over the study period. The proportions of females, those diagnosed with HIV infection more than five years ago, those already on ART, and those with low HIV-1 RNA load were significantly high among non-Japanese patients (*p*\<0.01, respectively). In other words, the proportions of males, recently diagnosed patients, treatment-naïve patients, and patients with over 1,000 copies/ml of viremia were high among Japanese patients.

10.1371/journal.pone.0205184.t001

###### Baseline characteristics of study population, 2011--2014.
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                             Non-Japanese (n = 78)   Japanese (n = 473)                  
  -------------------------- ----------------------- -------------------- ------- ------ ---------
  Overall                                                                                
                             78                      14.2                 473     85.8   \-
  Age                                                                                    
  0--19                      1                       1.3                  5       1.1    0.877
  20--29                     23                      26.5                 109     23.0   0.499
  30--39                     30                      38.5                 188     39.8   0.828
  40--49                     19                      24.4                 124     26.2   0.737
  50--59                     5                       6.4                  32      6.8    0.896
  60+                        0                       0.0                  15      3.2    \-
  Gender                                                                                 
  Male                       63                      81.7                 459     97.0   \<0.001
  Female                     15                      18.3                 14^a^   3.0    \<0.001
  Year of first visit                                                                    
  2011                       22                      30.5                 122     25.8   0.383
  2012                       15                      18.3                 131     27.7   0.081
  2013                       21                      25.6                 116     24.5   0.835
  2014                       20                      25.6                 104     22.0   0.481
  Time since HIV diagnosis                                                               
  \< 1 year                  53                      68.0                 394     83.3   \<0.001
  1 to 5 year                14                      18.0                 52      11.0   0.779
  \> 5 year                  11                      14.0                 27      5.7    0.007
  On ART                                                                                 
  Yes                        20                      25.6                 53      11.2   \<0.001
  No                         58                      74.4                 420     88.8   \<0.001
  CD4+ cell count                                                                        
  \< 200 /μl                 19                      25.6                 152     32.1   0.251
  ≥ 200 /μl                  59                      74.4                 321     67.9   0.251
  HIV-1 RNA                                                                              
  \< 1000 copies/ml          21                      25.6                 52      11.0   \<0.001
  ≥ 1000 copies/ml           57                      74.4                 421     89.0   \<0.001
  HIV stage                                                                              
  AIDS                       11                      14.1                 80      16.9   0.536
  AC                         47                      60.3                 356     75.3   0.006
  Symptomatic                8                       10.3                 23      4.9    0.055
  Others                     12                      15.4                 14      3.0    \<0.001

All data are as of first visit.

Female data include a Male-To-Female transgender.

AC stands for Asymptomatic Careers.

[Table 2](#pone.0205184.t002){ref-type="table"} picked up some migrant-specific factors to describe characteristics of non-Japanese patients' group. They were mostly from Asia (n = 37, 47.4%), reflecting geographical proximity, followed by Africa (n = 16, 20.5%) and North America (n = 9, 11.5%). There was no significant change in the proportion of patients according to regions of origin over the study period, except a marginal decrease in the number of new cases from the African region. China (including Taipei China) was the top country/territory of origin over the study period (n = 13, 16.7%). The number of new patients from China has remarkably increased since 2014, which is possibly in line with the global economic conditions and relaxation of Japanese immigration policy for an entry visa to Chinese citizens \[[@pone.0205184.ref007]\].

10.1371/journal.pone.0205184.t002

###### Profiles of non-Japanese participants (n = 78).
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                                                  n    \%
  ----------------------------------------------- ---- ------
  Region of origin                                     
  Asia                                            37   47.4
  Africa                                          16   20.5
  North America                                   9    11.5
  Latin America                                   7    9.0
  Europe                                          6    7.7
  Oceania                                         3    3.9
  National Health Insurance                            
  Eligible                                        71   91.0
  Not Eligible                                    7    9.0
  Japanese Language Proficiency                        
  Fluent/Native                                   21   26.9
  Conversation                                    27   34.6
  Poor/Words                                      29   37.2
  Unknown                                         1    1.3
  Alternative Communication with Hospital Staff        
  Use of English                                  47   59.5
  Use of Interpreter                              6    7.6

[Table 2](#pone.0205184.t002){ref-type="table"} also shows Japanese language proficiency by migrant patients. We categorized the level of speaking/listening ability into six levels: poor, words-only, conversational, fluent, native, and unknown. We considered the level \[poor\] to level \[conversational\] as insufficient for essential communication at the hospital, as they may not be adequate for patients to understand their usually complex medical condition. Based on these criteria, 71.8% (n = 56) had experienced incomplete communication on their own. English appeared to be the most frequently used language for basic interpersonal communication skills (BICS) during the regular visits to the hospital. Twenty-four out of the 78 migrant patients were from a country/territory where English was one of the native languages \[[@pone.0205184.ref008]\].

Regarding alternative modes of communication used by patients of foreign origin, 47 (60.0%) attempted direct conversation with staff using English, while six (7.6%) were accompanied by professional interpreters. During the study period, six used a charge-free professional interpreting service provided by the local government or charity/non-profit organizations in Spanish, Portuguese, Chinese, and Thai languages. There was no record of pay service use. Very few patients used professional interpreters on their initial visit. In most cases interpreters/counselors were arranged by the hospital staff and used for subsequent visits.

[Table 3](#pone.0205184.t003){ref-type="table"} shows the outcomes of the follow-up by incidence rate stratified by groups and factors. A total of 390 patients maintained their visits to the hospital over the study period, while 161 patients were censored. Further analysis suggested that the difference in retention rate was not significantly different between non-Japanese and Japanese (IR\[non-Japanese\] = 71.9 per 100,000 person-days, IR\[Japanese\] = 80.1 per 100,000 person-days, IRR = 0.89, *p* = 0.27).

10.1371/journal.pone.0205184.t003

###### Follow-up outcome between non-Japanese and Japanese patients.
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  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                         Non-Japanese (n = 78)   Japanese (n = 473)   IRR of\                                                                                                        
                                                                      LTF                                                                                                            
  ---------------------- ----------------------- -------------------- ------------ --------- --------- ----------- --------- ------------ ----------- --------- --------- ---------- ---------------------------------------------
  Overall                                                                                                                                                                            

                         52,872                  38 (71.9)            27 (51.1)    0 (0.0)   0 (0.0)   13 (24.6)   439,456   352 (80.1)   97 (22.1)   3 (0.0)   3 (0.0)   18 (4.1)   6.0[\*\*](#t003fn004){ref-type="table-fn"}

  Age, years old                                                                                                                                                                     

  0--29                  13,002                  6 (46.2)             14 (107.7)   \-        \-        4 (30.8)    89,161    70 (78.5)    36 (40.4)   0 (0.0)   0 (0.0)   8 (9.0)    3.43[\*](#t003fn003){ref-type="table-fn"}

  30--39                 15,641                  12 (76.7)            12 (76.7)    \-        \-        6 (38.4)    174,887   135 (77.2)   45 (25.7)   2 (1.1)   0 (0.0)   6 (3.4)    11.2[\*\*](#t003fn004){ref-type="table-fn"}

  40--49                 19,924                  16 (80.3)            1 (5.0)      \-        \-        2 (10.0)    123,830   108 (87.2)   11 (8.9)    1 (0.0)   1 (0.0)   3 (2.4)    4.1

  50+                    4,305                   4 (92.9)             0 (0.0)      \-        \-        1 (23.2)    51,578    39 (75.6)    5 (9.7)     0 (0.0)   2 (3.9)   1 (1.9)    12.0

  Gender                                                                                                                                                                             

  Male                   39,002                  30 (76.9)            22 (56.4)    \-        \-        11 (28.2)   423,793   339 (80.0)   97 (22.9)   3 (0.0)   3 (0.0)   17 (4.0)   7.0[\*\*](#t003fn004){ref-type="table-fn"}

  Female                 13,870                  8 (57.7)             5 (36.1)     \-        \-        2 (14.4)    15,663    13 (83.0)    0 (0.0)     0 (0.0)   0 (0.0)   1 (6.4)    2.3

  Year of first visit                                                                                                                                                                

  2011                   24,376                  11 (45.1)            7 (28.7)     \-        \-        4 (16.4)    168,456   90 (53.4)    25 (14.8)   1 (0.0)   2 (1.2)   4 (2.4)    6.9[\*\*](#t003fn004){ref-type="table-fn"}

  2012                   11,544                  7 (60.6)             6 (52.0)     \-        \-        2 (17.3)    133,422   92 (69.0)    32 (24.0)   0 (0.0)   1 (0.0)   6 (4.5)    3.9

  2013                   8,666                   7 (80.8)             8 (92.3)     \-        \-        6 (69.2)    87,724    86 (98.0)    25 (28.5)   1 (1.1)   0 (0.0)   4 (4.6)    15.2[\*\*](#t003fn004){ref-type="table-fn"}

  2014                   8,286                   13 (156.9)           6 (72.4)     \-        \-        1 (12.1)    49,854    84 (168.5)   15 (30.1)   1 (2.0)   0 (0.0)   4 (8.0)    1.5

  Time since diagnosis                                                                                                                                                               

  0--1 year              37,162                  29 (78.0)            19 (51.1)    \-        \-        5 (13.5)    371,945   302 (81.2)   74 (19.9)   1 (0.0)   2 (0.0)   15 (4.3)   3.3[\*](#t003fn003){ref-type="table-fn"}

  1--5 years             9,395                   5 (53.2)             7 (74.5)     \-        \-        2 (21.3)    45,233    32 (70.7)    16 (35.4)   2 (4.4)   1 (2.2)   1 (2.2)    9.6[\*](#t003fn003){ref-type="table-fn"}

  5 years+               6,315                   4 (63.3)             1 (15.8)     \-        \-        6 (95.0)    22,278    18 (80.8)    7 (31.4)    0 (0.0)   0 (0.0)   2 (9.0)    10.6[\*\*](#t003fn004){ref-type="table-fn"}

  On ART                                                                                                                                                                             

  Yes                    9,549                   5 (76.2)             9 (94.3)     \-        \-        6 (62.8)    45,079    36 (79.9)    12 (26.6)   2 (4.4)   0 (0.0)   3 (6.7)    9.4[\*\*](#t003fn004){ref-type="table-fn"}

  No                     43,323                  33 (52.4)            18 (41.6)    \-        \-        7 (16.2)    394,377   316 (80.1)   85 (21.6)   1 (0.0)   3 (0.0)   15 (3.8)   4.3[\*\*](#t003fn004){ref-type="table-fn"}

  CD4+ cell, count//μl                                                                                                                                                               

  \< 200                 15,018                  15 (99.9)            2 (13.3)     \-        \-        2 (13.3)    146,988   123 (83.7)   23 (15.7)   0 (0.0)   0 (0.0)   6 (4.1)    3.3

  ≥ 200                  37,854                  23 (60.8)            25 (66.0)    \-        \-        11 (29.1)   292,468   229 (78.3)   74 (25.3)   3 (1.0)   3 (1.0)   12 (3.2)   7.1[\*\*](#t003fn004){ref-type="table-fn"}

  HIV-1 RNA, copies/ml                                                                                                                                                               

  \< 1000                11,670                  7 (60.0)             9 (77.1)     \-        \-        5 (42.8)    46,207    35 (75.8)    12 (26.0)   2 (4.3)   0 (0.0)   3 (6.5)    6.6[\*\*](#t003fn004){ref-type="table-fn"}

  ≥ 1000                 41,202                  31 (75.2)            18 (43.7)    \-        \-        8 (19.4)    393,249   317 (80.6)   85 (21.6)   1 (0.0)   3 (0.0)   15 (3.8)   5.1[\*\*](#t003fn004){ref-type="table-fn"}

  HIV stage                                                                                                                                                                          

  AIDS                   7,980                   8 (100.3)            2 (25.1)     \-        \-        1 (12.5)    82,204    260 (81.5)   78 (9.7)    2 (1.2)   2 (1.2)   3 (3.7)    3.4

  AC                     29,920                  20 (66.8)            19 (63.5     \-        \-        8 (26.7)    337,746   67 (77.0)    8 (23.1)    1 (0.0)   1 (0.0)   14 (4.2)   6.5[\*\*](#t003fn004){ref-type="table-fn"}

  Symptomatic            9,316                   6 (64.4)             0 (0.0)      \-        \-        2 (21.5)    14,855    20 (134.6)   3 (20.2)    0 (0.0)   0 (0.0)   0 (0.0)    NA

  Others                 5,656                   4 (70.7)             6 (106.1)    \-        \-        2 (35.4)    4,651     5 (107.5)    8 (172.0)   0 (0.0)   0 (0.0)   1 (2.2)    1.6
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Characteristics as of the first visit. Japanese Female data include a Male-To-Female transgender.

IR stands for Incidence Rate per 100,000 person-days. IRR stands for Incident Rate Ratio. AC stands for Asymptomatic Carriers.

\* p\<0.05

\*\* p\<0.01.

The primary reason for censoring is referral to another clinical facility. All 97 referrals of Japanese were addressed to hospitals and clinics in Japan, while eight out of 27 non-Japanese cases were addressed to an unspecified recipient in their home countries, as they returned to their country of origin.

The second major reason for censoring was LTF (31 cases). The overall LTF rate was significantly higher among migrant patients compared to Japanese Patients (IRR = 6.0, *p*\<0.01)

To analyze the factors associated with high LTF among non-Japanese patients, we conducted regression analysis using Poisson regression model. [Table 4](#pone.0205184.t004){ref-type="table"} shows the results of analysis of the associations among sociocultural factors and LTF in migrant patients. Univariate regression results suggested that the incidence rate of LTF increased 4.38 times among non-Japanese (*p*\<0.01), 2.68 times among patients on ART in the initial visit (*p* = 0.01), and 1.37 times with each additional year since the time of diagnosis (*p*\<0.01). On the other hand, LTF rate decreased by 56% among those with over 1,000 copies/ml of HIV-1 RNA (*p* = 0.05).

10.1371/journal.pone.0205184.t004

###### Results of Poisson regression analyses (n = 551).
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                                   Univariable Analysis   Multivariable Model (A)   Multivariable Model (B)                                
  -------------------------------- ---------------------- ------------------------- ------------------------- -------- ------------------- --------
  Non-Japanese                     4.38 (2.15--8.94)      \<0.01                    3.60 (1.72--7.51)         \<0.01   3.65 (1.76--7.59)   \<0.01
  Age at enrolment                 0.97 (0.93--1.00)      0.11                                                                             
  Male gender                      0.52 (0.16--1.70)      0.28                                                                             
  Year of enrolment                0.96 (0.70--1.32)      0.80                                                                             
  On ART                           2.68 (1.23--5.82)      0.01                      1.16 (0.37--3.68)         0.79                         
  CD4+ cell count≥200/μl           1.29 (0.58--2.89)      0.53                                                                             
  HIV-1 RNA\>1000 copies/ml        0.44 (0.20--0.98)      0.05                      0.96 (0.33--2.81)         0.95                         
  Time since HIV diagnosis, year   1.37 (1.16--1.61)      \<0.01                    1.26 (1.03--1.55)         0.03     1.29 (1.09--1.53)   \<0.01

All variables with a *p*\<0.1 in the univariable analyses were submitted in multivariable model (A). Likewise, all variables with a *p*\<0.1 in model (A) were submitted in the model (B)

There was no significant difference detected in gender, year of first visit (enrollment into the study), CD4+ cell count at initial visit.

By submitting variables with *p*\<0.1 in the univariable analysis and multivariable analysis, we came up with a regression model with variables of a difference of non-Japanese/Japanese and time since diagnosis. The estimated LTF rate was increased 3.65 times among non-Japanese patients (IRR = 3.65, 95%CI: 1.76--7.59, *p*\<0.01, [Table 4](#pone.0205184.t004){ref-type="table"}.).

In addition, we have conducted an analysis using Cox Hazard Model to evaluate the effect of alternative communication tools (e.g. the use of English and an interpreter). We detected little evidence of risk reduction in the use of English and the use of an interpreter for communication with hospital staff (hazard ratio = 0.58, *p* = 0.32, hazard ratio = 1.87, *p* = 0.42, respectively).

Among 31 cases who were lost-to-follow-up within the study period, [Table 5](#pone.0205184.t005){ref-type="table"} picked up the profiles of the 13 non-Japanese cases. Many of these cases had limited proficiency in Japanese language. Six out of the 13 used English as an alternative mode of communication, and only a few used professional interpreters. All but one had legal status in Japan with a valid stay permit at the time of the initial visit, which implies that 12 (with one exception) were deemed eligible for public health insurance. It was anticipated that disclosure of their HIV status to friends or partners would help with continuity of their follow-up. A few had disclosed their status, but were still lost-to-follow-up. Some patients were from countries that offered free ART, so it was considered possible that they could have received treatment if they had gone back to their country. We hoped that they had returned to their countries of origin; however, their whereabouts are unknown.

10.1371/journal.pone.0205184.t005

###### Profiles of the non-Japanese patients who were lost-to-follow-up during the study period (n = 13).
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   Time to attrition\   Gender   CD4+ count/μl\   Japanese language\   English use   Interpreter use   Disclosure of HIV   Legal status   Region of origin   ART in\
         (Days)                        at first visit   proficiency                                                                                                home country[^1)^](#t005fn001){ref-type="table-fn"}^--^[^3)^](#t005fn003){ref-type="table-fn"}
  ------ -------------------- -------- ---------------- -------------------- ------------- ----------------- ------------------- -------------- ------------------ ------------------------------------------------------------------------------------------------
  1      1                    M        344              Conversation         Yes           No                Yes                 Yes            Asia               Subsidized

  2      7                    M        341              Conversation         Yes           No                None                Yes            Oceania            Free

  3      29                   M        282              Conversation         Yes           Yes               Yes                 Yes            Latin America      Free

  4      29                   M        637              Fluent               No            No                Unknown             Yes            Latin America      Free

  5      32                   F        423              Words only           Yes           No                None                Yes            Africa             Free

  6      43                   M        181              Words only           No            No                None                No             Africa             No

  7      85                   M        275              Poor                 No            No                Yes                 Yes            Africa             No

  8      107                  M        373              Fluent               No            No                None                Yes            Asia               Free

  9      135                  M        322              Poor                 Yes           No                None                Yes            North America      Conditional

  10     482                  M        291              Native               No            No                Yes                 Yes            Asia               Subsidized

  11     644                  F        773              Conversation         No            No                Yes                 Yes            Asia               Subsidized

  12     680                  M        280              Conversation         Yes           No                No                  Yes            Europe             Free

  13     1180                 M        135              Fluent               No            No                Yes                 Yes            Asia               Subsidized
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1)^WHO; Countries offering free access to HIV treatment; Developing Countries & Free Access Fact Sheet; December 2005.

^2)^WHO; Democratic Republic of the Congo; Summary Country Profile for HIV/AIDS Treatment Scale-Up; December 2005.

^3)^UNAIDS; Access to antiretroviral therapy in Africa; status report on progress towards the 2015 targets; 2013.

Discussion {#sec004}
==========

Among the study population, we did not detect a difference in retention rate between migrant patients and Japanese patients. On the other hand, we have detected a significant increase in censoring among non-Japanese. The discordant result may be explained by the timing of censoring. The primary reasons for censoring were the transfer of care to another hospital/clinic and LTF. As we mentioned earlier, we try to transfer migrant patients to another hospital/clinic as soon as we finish the initial medical assessment. We also have results that many of the loss-to-follow-up cases occurred within 90 days following the first visit. Therefore, if the event of censoring occurred relatively earlier among migrant patients, the incident rate would be increased significantly.

An early dropout generates concern that some patients stopped visiting our center before we completed their initial assessment and ensured the provision of essential information. It highlights the difficulty in the establishment of care compared to its continuation \[[@pone.0205184.ref009]\]. Providing clinical care to people living with HIV/AIDS (PLWHA) is important from a public health point of view. Failure to establish HIV/AIDS care and leaving patients untreated is a potential risk of secondary infection with the possible spread of the virus to families or communities unless the patients return to their home country to seek treatment.

Adequate provision of social support information in the first stage of the visit is therefore critical for retention of patients of foreign origin in continuous HIV/AIDS care \[[@pone.0205184.ref010]\]. This information must emphasize the availability of public support systems to all patients, regardless of their country of origin. Those who are from a country where the government ill-treats PLWHA may be overly concerned about how the Japanese government will treat them as aliens. Case-specific information may also be necessary, such as support options available for asylum seekers (unrecognized refugees), long-term care options and age-related welfare services available in Japan for permanent-stay permit holders.

The high loss-to-follow-up rate among migrant patients is in line with previous studies that suggested an increased risk of non-adherence to ART among immigrant patients \[[@pone.0205184.ref011]--[@pone.0205184.ref014]\]. Some of the extant literature in this field indicated that limited social support is the primary factor for the dropout. If patients are not eligible for the government subsidy and their levels of social support become weak, they are then unlikely to adhere to the treatment \[[@pone.0205184.ref015]\]. However, there are conflicting results in this study that suggest the loss-to-follow-up rate was not statistically significant for legal status. Moreover, most of the loss-to-follow-up cases were eligible for government assistance. Therefore, we cannot determine at this stage whether legal status was the main reason for the high dropout rate among migrant patients. The cause of loss-to-follow-up is not likely to be an actual rejection of social service applications, but rather the fear of rejection because of social status as a foreigner. If individuals are unaware of their eligibility for social service, they may give up on treatment out of fear that they cannot afford it.

Another possible cause of loss-to-follow-up among migrant patients is poor patient-staff communication and subsequent lack of social support information. Although the results of this research did not provide substantial evidence, many of the early loss-to-follow-up cases were not fluent in the Japanese language. No doubt it is hard to build patient--staff trust and to determine whether Japanese language proficiency is insufficient, which is crucial to establishing HIV/AIDS care \[[@pone.0205184.ref016]\]. Thus, limited verbal communication between hospital staff and patients appeared to be one of the factors responsible for the low retention rate.

Some of the patients used alternative methods of communication, such as using English for direct communication, or the help of a professional interpreter. Despite the effort of alternative communication, we did not detect a significant risk reduction in drop-out through the alternative modes of communication. The small sample size may not be the only reason for this. First, English is usually the second language for both migrant patients and hospital staff. Second, the availability of translation tools is limited to some charge-free services because ACC does not have a specific budget allocation to cover the cost of pay service.

We sometimes experience a service preference gap. Hospital staff prefer a face-to-face interpretation service as they believe it to be more reliable, convenient, and flexible, but some patients prefer a telephone interpreter service to enable them to hide their identity from the translator who is sometimes an acquaintance of the patient. Some patients refuse to seek the help of native speakers as they fear it will jeopardize their confidentiality among resident colleagues in Japan, particularly when their local community is small. The challenge is to find the means to ensure reliability and confidentiality of the translation service to both patients and hospital staff. The use of professional interpretation is more promising compared to the unreliable use of English, because the hospital-wide telephone interpretation service has recently become available in several languages, and the choice is available to more people.

Although previous studies identified several factors as possibly being associated with retention in care \[[@pone.0205184.ref017]--[@pone.0205184.ref021]\], we did not collect the following information: local support networks for migrant patients, mental health conditions, socioeconomic status, transportation, housing, and food security. We detected an association between early LTF and the time period since HIV diagnosis, there was little evidence of an association with retention. Further research is needed in this field since our study did not detect other factors associated with loss-to-follow-up among migrant patients.

Conclusion {#sec005}
==========

The results of the study suggested a significantly higher dropout rate of migrant patients with HIV/AIDS who sought care at the hospital compared to that of Japanese patients. Nevertheless, we did not detect an apparent association between retention and the factors peculiar to migrants. There was no evidence of risk reduction owing to the current communication assistance (e.g. interpretation service) that we are providing. Further studies are needed to analyze factors of high dropout and address the issue of migrant PLWHA to improve retention in HIV/AIDS care.
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